2211 Stock Overview
An investment holding company, distributes and retails drugs, healthcare products, and other pharmaceutical products in the northeastern region of the People’s Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Universal Health International Group Holding Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.16 |
| 52 Week High | HK$0.25 |
| 52 Week Low | HK$0.041 |
| Beta | -0.12 |
| 1 Month Change | 54.72% |
| 3 Month Change | 130.99% |
| 1 Year Change | 76.34% |
| 3 Year Change | 7.19% |
| 5 Year Change | -65.83% |
| Change since IPO | -99.31% |
Recent News & Updates
Shareholder Returns
| 2211 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | 30.2% | -1.3% | -0.5% |
| 1Y | 76.3% | -17.8% | 19.9% |
Return vs Industry: 2211 exceeded the Hong Kong Healthcare industry which returned -17.8% over the past year.
Return vs Market: 2211 exceeded the Hong Kong Market which returned 19.9% over the past year.
Price Volatility
| 2211 volatility | |
|---|---|
| 2211 Average Weekly Movement | 23.0% |
| Healthcare Industry Average Movement | 8.3% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in HK Market | 18.6% |
| 10% least volatile stocks in HK Market | 4.1% |
Stable Share Price: 2211's share price has been volatile over the past 3 months compared to the Hong Kong market.
Volatility Over Time: 2211's weekly volatility has increased from 17% to 23% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 1,286 | Chuanfu Chu | www.uhighl.com |
Universal Health International Group Holding Limited, an investment holding company, distributes and retails drugs, healthcare products, and other pharmaceutical products in the northeastern region of the People’s Republic of China. Its product categories include Chinese patent medicines, chemical preparations, antibiotics and biochemical drugs, traditional Chinese medicine decoction pieces, biological products, protein assimilation preparations, peptide hormones, disinfection products, blood products, medical equipment, prepackaged food, health care products, nutritional food, stereotyped packaging cosmetics, and daily necessities, as well as family planning supplies, such as contraceptives and utensils; and dairy products, including infant formula milk powder. The company also provides storage services.
Universal Health International Group Holding Limited Fundamentals Summary
| 2211 fundamental statistics | |
|---|---|
| Market cap | HK$131.37m |
| Earnings (TTM) | HK$440.14k |
| Revenue (TTM) | HK$1.16b |
298.5x
P/E Ratio0.1x
P/S RatioIs 2211 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2211 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.09b |
| Cost of Revenue | CN¥909.15m |
| Gross Profit | CN¥179.89m |
| Other Expenses | CN¥179.47m |
| Earnings | CN¥413.00k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.00052 |
| Gross Margin | 16.52% |
| Net Profit Margin | 0.038% |
| Debt/Equity Ratio | 20.0% |
How did 2211 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 12:27 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Universal Health International Group Holding Limited is covered by 7 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yue-Kwong Lui | BOCOM International Securities Limited |
| Yue-Kwong Lui | CGS International |
| Hoi Yin Yip | China Everbright Research Limited |